Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin J Shattock

Showing results (171-180 of 210) with videos related to

Pageof 21
Sort By:
Plos One|October 11, 2011
Phase I randomised clinical trial of an HIV-1(CN54), clade C, trimeric envelope vaccine candidate delivered vaginallyDavid J Lewis, Carol A Fraser, Abdel N Mahmoud, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 26, 2011
Non-aqueous silicone elastomer gels as a vaginal microbicide delivery system for the HIV-1 entry inhibitor maravirocClaire J Forbes, Deborah Lowry, Leslie Geer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2009
Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide componentBarry R O'Keefe, Fakhrieh Vojdani, Viviana Buffa, et al.
Molecular Therapy. Nucleic Acids|January 2, 2023
Formulation, inflammation, and RNA sensing impact the immunogenicity of self-amplifying RNA vaccinesJohn S Tregoning, David C Stirling, Ziyin Wang, et al.
NPJ Vaccines|August 18, 2021
Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimersKwinten Sliepen, Edith Schermer, Ilja Bontjer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2018
Unexpected synergistic HIV neutralization by a triple microbicide produced in rice endospermEvangelia Vamvaka, Gemma Farré, Luis M Molinos-Albert, et al.
ACS Nano|January 27, 2026
Polyanion Chemistry Engineers Ternary RNA Nanoparticle Structure/Function from the Inside-OutLijun Hu, David J Peeler, Tianyi Jin, et al.
NPJ Vaccines|November 3, 2021
Author Correction: Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimersKwinten Sliepen, Edith Schermer, Ilja Bontjer, et al.
Journal of Translational Medicine|July 13, 2012
Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011Nicolas Ruffin, Marie Borggren, Zelda Euler, et al.
Nature Communications|July 11, 2020
Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in micePaul F McKay, Kai Hu, Anna K Blakney, et al.
Pageof 21

Showing results (171-180 of 210) with videos related to

Sort By:
Pageof 21
Plos One|October 11, 2011
Phase I randomised clinical trial of an HIV-1(CN54), clade C, trimeric envelope vaccine candidate delivered vaginallyDavid J Lewis, Carol A Fraser, Abdel N Mahmoud, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 26, 2011
Non-aqueous silicone elastomer gels as a vaginal microbicide delivery system for the HIV-1 entry inhibitor maravirocClaire J Forbes, Deborah Lowry, Leslie Geer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2009
Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide componentBarry R O'Keefe, Fakhrieh Vojdani, Viviana Buffa, et al.
Molecular Therapy. Nucleic Acids|January 2, 2023
Formulation, inflammation, and RNA sensing impact the immunogenicity of self-amplifying RNA vaccinesJohn S Tregoning, David C Stirling, Ziyin Wang, et al.
NPJ Vaccines|August 18, 2021
Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimersKwinten Sliepen, Edith Schermer, Ilja Bontjer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2018
Unexpected synergistic HIV neutralization by a triple microbicide produced in rice endospermEvangelia Vamvaka, Gemma Farré, Luis M Molinos-Albert, et al.
ACS Nano|January 27, 2026
Polyanion Chemistry Engineers Ternary RNA Nanoparticle Structure/Function from the Inside-OutLijun Hu, David J Peeler, Tianyi Jin, et al.
NPJ Vaccines|November 3, 2021
Author Correction: Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimersKwinten Sliepen, Edith Schermer, Ilja Bontjer, et al.
Journal of Translational Medicine|July 13, 2012
Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011Nicolas Ruffin, Marie Borggren, Zelda Euler, et al.
Nature Communications|July 11, 2020
Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in micePaul F McKay, Kai Hu, Anna K Blakney, et al.
Pageof 21